Novel feature extraction technique for fuzzy relational clustering of a flexible dopamine reuptake inhibitor

Journal of Chemical Information and Modeling

Volumn 45, Issue 3, 2005, Pages 610-623

  Misra, Milind ^a   Banerjee, Amit ^b   Davé, Rajesh N ^b   Venanzi, Carol A ^a  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

^b NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; CONFORMATIONS; FUZZY CONTROL; FUZZY SETS; HIERARCHICAL SYSTEMS; MOLECULAR STRUCTURE; POTENTIAL ENERGY; RELATIONAL DATABASE SYSTEMS;

COMPARATIVE MOLECULAR FIELD ANALYSIS (COMFA); CONFORMATIONAL SPACE; FUZZY RELATIONAL CLUSTERING; GLOBAL ENERGY MINIMUM (GEM) CONFORMATIONS; HIERARCHICAL CLUSTERING;

FEATURE EXTRACTION;

DOPAMINE UPTAKE INHIBITOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CLUSTER ANALYSIS; CONFORMATION; FUZZY LOGIC;

CLUSTER ANALYSIS; DOPAMINE UPTAKE INHIBITORS; FUZZY LOGIC; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE;

EID: 20444365845     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci049708d     Document Type: Article

References (45)

1. Nicklaus, M. C.; Wang, S.; Driscoll, J. S.; Milne, G. W. Conformational changes of small molecules binding to proteins. Bioorg. Med. Chem. 1995, 3, 411-428.
2. Veith, M.; Hirst, J. D.; Brooks III, C. L. Do active site conformations of small ligands correspond to low free-energy solution structures? J. Comput.-Aided Mol. Des. 1998, 12, 563-572.
3. Debnath, A. K. Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: Application of Comparative Molecular Field Analysis. J. Med. Chem. 1999, 42, 249-259.
4. Perola, E.; Charifson, P. S. Conformational analysis of drug-like molecules bound to proteins: An extensive study of ligand reorganization upon binding. J. Med. Chem. 2004, 47, 2499-2510.
5. Guarnieri, F.; Weinstein, H. Conformational memories and the exploration of biologically relevant peptide conformations: An illustration for the gonadotropin-releasing hormone. J. Am. Chem. Soc. 1996, 118, 5580-5589.
6. Hopfinger, A. J.; Tokarski, J. S. Three-dimensional quantitative structure - activity relation analysis. In Practical Application of Computer-Aided Drug Design; Charifson, P. S., Ed.; Marcel Dekker: New York, 1997; Vol. 105-164.
7. Barnett-Norris, J.; Guarnieri, F.; Hurst, D. P.; Reggio, P. H. Exploration of biologically relevant conformations of anandamide, 2-arachidonyl-glycerol, and their analogues using conformational memories. J. Med. Chem. 1998, 41, 4861-4872.
8. Barnett-Norris, J.; Hurst, D. P.; Lynch, D. L.; Guarnieri, F.; Makriyanis, A.; Reggio, P. H. Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor. J. Med. Chem. 2002, 45, 3649-3659.
9. Greenidge, P. A.; Merette, S. A.; Beck, R.; Dodson, G.; Goodwin, C. A.; Scully, M. F.; Spencer, J.; Weiser, J.; Deadman, J. J. Generation of ligand conformations in continuum solvent consistent with protein active site topology: Application to thrombin. J. Med. Chem. 2003, 46, 1293-1305.
10. Bernard, D.; Coop, A.; MacKerell, A. D., Jr. 2D conformationally sampled pharmacophore: A ligand based pharmacophore to differentiate delta opioid agonists from antagonists. J. Am. Chem. Soc. 2003, 125, 3101-3107.
11. Cramer III, R. D.; Patterson, D. E.; Bunce, J. D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
12. Glowa, J. R.; Fantegrossi, W. E.; Lewis, D. B.; Matecka, D.; Rice, K. C.; Rothman, R. B. Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis(4-fluorophenyl)methoxy]-ethyl]-4-(3-hydroxyl- 3phenylpropyl)piperazinyl decanoate, a long-acting ester derivative of GBR 12909. J. Med. Chem. 1996, 39, 4689-4691.
13. Prisinzano, T.; Rice, K. C.; Baumann, M. H.; Rothman, R. B. Development of neurochemical normalization ("agonist substitution") therapeutics for stimulant abuse: Focus on the dopamine uptake inhibitor, GBR12909. Curr. Med. Chem. CNS Agents 2004, 4, 47-59.
14. Lewis, D. B.; Matecka, D.; Zhang, Y.; Hsin, L. W.; Dersch, C. M.; Stafford, D.; Glowa, J. R.; Rothman, R. B.; Rice, K. C. Oxygenated analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3- phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents. J. Med. Chem. 1999, 42, 5029-5042.
15. Downs, G. M.; Barnard, J. M. Clustering methods and their uses in computational chemistry. In Reviews in Computational Chemistry; Lipkowitz, K. B., Boyd, D. B., Eds.; VCH: New York, 2002; Vol. 18, pp 1-40.
16. Shenkin, P. S.; McDonald, D. Q. Cluster analysis of molecular conformations. J. Comput. Chem. 1994, 15, 899-916.
17. Murray-Rust, P.; Raftery, J. Computer analysis of molecular geometry, part IV: Classification of differences in conformation. J. Mol. Graph. 1985, 3, 50-59.
18. Jain, A. K.; Dubes, R. C. Algorithms for Clustering Data; Prentice Hall, NJ, 1988.
19. Johnson, R. A.; Wichern, D. W. Applied Multivariate Statistical Analysis, 4th ed.; Prentice-Hall: NJ, 1998.
20. Duda, R. O.; Hart, P. E.; Stork, D. G. Pattern Classification, 2nd ed.; John Wiley: New York, 2000.
21. Chema, D.; Goldblum, A. The nearest neighbor method - Finding families of conformations within a sample. J. Chem. Inf. Comput. Sci. 2003, 43, 208-217.
22. Feher, M.; Schmidt, J. M. Metric and multidimensional scaling: Efficient tools for clustering molecular conformations. J. Chem. Inf. Comput. Sci. 2001, 41, 346-353.
23. Feher, M.; Schmidt, J. M. Fuzzy clustering as a means of selecting representative conformers and molecular alignments. J. Chem. Inf. Comput. Sci. 2003, 43, 810-818.
24. Bezdek, J. C. Pattern Recognition with Fuzzy Objective Function Algorithms; Plenum Press: New York, 1981.
25. Bezdek, J. C.; Keller, J.; Krishnapurum, R.; Pal, N. Fuzzy Models and Algorithms for Pattern Recognition and Image Processing; Kluwer Academic Publishers: Norwell, MA, 1999.
26. Davé, R. N.; Bhaswan, K. Adaptive fuzzy C-shells clustering and detection of ellipses. IEEE Trans. Neural Net. 1992, 3, 643-662.
27. Davé, R. N.; Krishnapurum, R. Robust clustering methods: A unified view. IEEE Trans. Fuzzy Syst. 1997, 5, 270-293.
28. Xie, X. L.; Beni, G. A validity measure for fuzzy clustering. IEEE Trans. Patt. Anal. Machine Intell. 1991, 13, 841-847.
29. Davé, R. N. Validating fuzzy partitions obtained through c-shells clustering. Pattern Recognit. Lett. 1996, 17, 613-623.
30. Tucker, W. T. Counterexamples to the convergence theorem for the fuzzy c-means clustering algorithms. In Analysis of Fuzzy Information; Bezdek, J. C., Ed.; CRC Press: Boca Raton, FL, 1987; Vol. III, pp 109-121.
31. Höppner, F.; Klawonn, F. Obtaining interpretable fuzzy models from fuzzy clustering and fuzzy regression. Proc. of the 4th Int. Conf. on Knowledge-Based Intelligent Engineering Systems and Allied Technologies (KES): Brighton, U.K., 2000; pp 162-165.
32. Höppner, F.; Klawonn, F.; Eklund, P. Learning indistinguishability from data. Soft Comput. J. 2002, 6, 6-13.
33. Hathaway, R. J.; Bezdek, J. C. NERF c-means: Non-Euclidean relational fuzzy clustering. Pattern Recognit. 1994, 24, 429-437.
34. Dave, R. N.; Sen, S. Robust fuzzy clustering of relational data. IEEE Trans. Fuzzy Syst. 2002, 10, 713-727.
35. Shannon, C. E. A mathematical theory of communication. Bell Syst. Technol. J. 1948, 27, 379-423.
36. Gath, I.; Geva, A. B. Unsupervised optimal fuzzy clustering. IEEE Trans. Patt. Anal. Machine Intell. 1989, 11, 773-781.
37. SYBYL 6.9 Tripos Inc.; 1699 South Hanley Rd., St. Louis, Missouri, 63144, USA.
38. Dutta, A. K.; Meltzer, P. C.; Madras, B. K. Positional importance of the nitrogen atom in novel piperidine analogues of GBR 12909: Affinity and selectivity for the dopamine transporter. Med. Chem. Res. 1993, 3, 209-222.
39. Powell, M. J. D. Restart procedures for the conjugate gradient method. Math. Program. 1977, 12, 241-254.
40. Clark, M.; Cramer III, R. D.; van Opdenbosch, N. Validation of the general purpose Tripos 5.2 force field. J. Comput. Chem. 1989, 10, 982-1012.
41. Matecka, D.; Lewis, D.; Rothman, R. B.; Dersch, C. M.; Wojnicki, F. H. E.; Glowa, J. R.; DeVries, A. C.; Pert, A.; Rice, K. C. Heteroatomic analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4- (3-phenylpropyl)piperazines(GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors. J. Med. Chem. 1997, 40, 705-716.
42. Hsin, L. W.; Dersch, C. M.; Baumann, M. H.; Stafford, D.; Glowa, J. R.; Rothman, R. B.; Jacobson, A. E.; Rice, K. C. Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: Chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3- phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl) piperazine. J. Med. Chem. 2002, 45, 1321-1329.
43. Lewis, D.; Zhang, Y.; Prisinzano, T.; Dersch, C. M.; Rothman, R. B.; Jacobson, A. E.; Rice, K. C. Further exploration of 1-{2-[bis-(4-fluorophenyl) methoxy]ethyl}piperazine (GBR 12909): Role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl substituents on affinity for the dopamine and serotonin transporter. Bioorg. Med. Chem. Lett. 2003, 13, 1385-1389.
44. Saunders: M. Stochastic exploration of molecular mechanics energy surfaces. Hunting for the global minimum. J. Am. Chem. Soc. 1987, 109, 3150-3152.
45. Gilbert, K. M.; Venanzi, C. A. Unpublished results.